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Atherectomy is a new therapeutic intervention for the
treatment of peripheral arterial disease, and permits the
controlled excision and retrieval of portions of stenosing
lesions. The gross and light microscopic features of 218
peripheral arterial stenoses resected from 100 patients by
atherectomy were studied. One hundred seventy of these
lesions were primary stenoses and 48 were restenoses
subsequent to prior angioplasty or atherectomy. Micro-
scopically, primary stenoses were composed of atheroscle-
rotic plaque (150 lesions), fibrous intimal thickening (15
lesions) or thrombus alone (5 lesions). Atherosclerotic
plaques had a variable morphology and, in one-third of
cases, were accompanied by abundant surface thrombus
that probably added to the severity of stenosis. Most
patients with fibrous intimal thickening or thrombus alone
Percutaneous directed atherectomy uses a transluminal ap-
proach to remove segments of atherosclerotic plaque and
thrombus from diseased arteries (1). Histopathologic assess-
ment of tissues retrieved in this manner can clarify the
nature of vascular disease in individual patients and may
provide insight into the pathogenesis of restenosis after
vascular interventions. The purpose of this study was to
describe the gross and microscopic features of peripheral
arterial stenoses excised from the first 100 patients treated
by atherectomy at Sequoia Hospital, Redwood City, Cali-
fornia. Specimens from previously untreated primary steno-
ses were compared with those from restenoses that had
developed after angioplasty or atherectomy. Finally, the
histopathologic features of angioplasty and atherectomy
restenoses were compared, and clinical factors were ana-
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had typical atherosclerotic plaque removed elsewhere from
within the same artery.
Intimal hyperplasia, with or without underlying resid-
ual plaque, was found at 36 sites of restenosis, the remain-
ing 12 consisting of plaque only. Intimal hyperplasia had a
distinctive histologic appearance and was due to smooth
muscle cell proliferation within a loosely fibrous stroma.
Superimposed thrombus may have contributed to arterial
narrowing in 25% of hyperplastic and 8% of atheroscle-
rotic restenoses (p = 0.41). Pathologic examination of
tissues recovered by peripheral atherectomy is an impor-
tant adjunct that may provide insight into the efficacy of
vascular interventions and the phenomenon of postinter-
vention restenosis.
(J Am Coil CardioI1990;15:419-25)
lyzed in correlation with the morphologic features of re-
stenosis.
Methods
Study patients. All treated patients had symptomatic
peripheral arterial disease with exercise-induced or rest
claudication. At least one focal stenosis was documented
angiographically and by Doppler study in every patient.
Aspirin (375 mg four times daily) and, for many patients,
dipyridamole (75 mg three times daily) were administered
beginning 1 day before the procedure and continuing for 6
months thereafter. Heparin (10,000 U) was administered
through the intravascular sheath, and its effect was not
reversed with protamine after atherectomy. Occasionally, a
patient required long-term oral anticoagulation with Couma-
din (warfarin) because of preexisting or postprocedural
thrombosis.
Clinical evaluations and Doppler studies were performed
at 2, 6 and 12 month intervals after the procedure and at any
time for patients with recurrence of symptoms. Angiography
0735-1097/90/$3.50
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Figure 1. Flow diagram for 218 arterial stenoses resected from 100
patients. PTA = percutaneous transluminal balloon angioplasty.
218 lesions (1~atientS)
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atherectomy atherectomy t
92 years (mean 65.6). Atherectomy was successful in 91
patients (91%); a successful procedure was defined as reduc-
tion of the angiographic stenosis to <45%.
Atherectomy was attempted in 220 stenoses and resulted
in removal a/tissue at 218 a/the 220 sites (Fig. 1). No tissue
was retrieved from two iliac artery lesions because the
available catheters were undersized relative to the lumen
size. Fifty-four patients had two or more separate lesions
treated by atherectomy. Twenty-four stenoses were located
in the common or external iliac artery, 169 in the superficial
femoral artery, 1in the profunda femoris, 23 in the popliteal
artery and 3 in the anterior or posterior tibial arteries. One
hundred seventy lesions removed from 89 patients were
primary stenoses that had not been treated previously by any
vascular intervention (Fig. 1). Repeat atherectomy was
performed at the site of 29 of these lesions in 16 patients
because of subsequent restenosis. Eleven patients had a
total of 15 lesions excised that were restenoses that occurred
after balloon angioplasty. Four of these sites from three
patients required a second atherectomy for recurrent re-
stenosis. Overall, 48 lesions removed from 27 patients were
restenoses that had developed after angioplasty alone (15
lesions), atherectomy alone (29 lesions), or both procedures
(4 lesions).
Gross pathology. A total of 1,482 tissue samples were
excised from 218 stenoses. The cutter was advanced forward
1 to 27 times (mean 6.7 passes) and 1 to 49 tissue samples
(mean 8) were obtained at each site. The specimens were
usually rectangular strips of tissue. Sample size varied and
was dependent on the dimensions of the catheter employed.
The gross morphology of samples was highly variable,
ranging from translucent strips of tan-white tissue to opaque
white-yellow tissue with brown areas corresponding to
thrombus (Fig. 2A). Gritty nodules representing calcified
areas were frequently observed. Samples obtained from five
lesions appeared grossly to consist entirely of red-brown
thrombus. Specimens removed from sites of restenosis fre-
quently appeared had two layers, with white-gray myxoid
tissue overlying white-yellow atherosclerotic plaque.
was performed in all consenting patients at 6 months. The
Human Research Committee of Sequoia Hospital approved
the study protocol, and all patients gave informed written
consent before atherectomy.
Catheter system and atherectomy procedure. The Simp-
son peripheral atherectomy catheter (Devices for Vascular
Intervention) and the procedure employed have been previ-
ously described (1). Briefly, the device has a combined
mechanism for both excision and retrieval of strips of
atherosclerotic plaque or thrombus. A housing at the distal
end has a longitudinal opening within which sits a rotating,
motor-driven cutting element. The length of this opening
varies with the type ofcatheter used and ranges from 15 to 20
mm. Along the backside of the housing is a support balloon
member that is inflated to low pressures to stabilize the
housing. The atherectomy catheter is inserted percutane-
ously through a sheath, and the housing is positioned across
the stenosis. The support balloon is then inflated to hold the
housing snugly against the plaque. The motor-driven cutter
is activated, rotating at 2,000 rpm, and is slowly advanced
forward, shaving away strips of plaque that are deposited
into a distal collection area. After several passes with the
cutter, the balloon is deflated and the device withdrawn from
the vessel. In our experience, 7F, 9F and llF devices have
been used for peripheral arterial disease. Recently, a cathe-
ter with an extended collection chamber has been developed
to allow for storage of as many as 20 tissue samples.
Tissue preparation. Tissue samples were carefully re-
moved from the collection area of the device with small
forceps, and gently laid flat between thin pieces of filter
paper. Tissues were fixed overnight in 10% buffered formalin
and, in some cases, placed briefly in an acidic decalcifying
solution. The length, width and depth of specimens were
measured with a dissecting microscope. Tissues were pro-
cessed routinely for histologic study and embedded on edge
in paraffin. Tissue sections (4 /Lm thick) were cut and stained
with hematoxylin-eosin, Masson's trichrome and elastic van
Gieson's stain. The Frazier-Lendrum stain for fibrin, von
Kossa's stain for calcium and Alcian blue for acid muco-
polysaccharides were also used in some cases. To ade-
quately assess these samples microscopically, three to six
slides were prepared at various levels through the paraffin
block, such that 75% to 100% of each block was sectioned.
Statistics were calculated with use of chi-square contin-
gency table analysis and a two-tailed, unpaired Student's t
test.
Results
Clinical results. One hundred patients with symptomatic
peripheral arterial disease were treated by transluminal
atherectomy between August 1985 and May 1988 using the
Simpson peripheral atherectomy catheter. Seventy-one pa-
tients were male, and the age range of all patients was 39 to
29 post-atherectomy
restenoses
(16 patients)
4 post-atherectomy restenoses
(3 patients)
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Figure 2. A, Strip of atherosclerotic plaque removed by atherectomy
showing the smooth cut surface. B, Atherosclerotic plaque with
fibrous cap covering a pale, lipid-rich zone (Masson's trichrome
stain). C, Surface thrombus coating an atherosclerotic lesion with
focal intraplaque hemorrhage (hematoxylin-eosin stain).
Microscopic Pathology
Primary stenoses. Three histologically different lesions
were identified as primary, previously untreated stenoses
(Table 1): I) atherosclerotic plaque, 2) fibrous intimal thick-
ening, and 3) organizing thrombus alone, unaccompanied by
arterial wall.
Atherosclerotic plaque. Of 170 primary stenoses from 89
patients, 150 (88%) consisted of typical atherosclerotic
plaque. Plaques were composed of dense fibrous tissue and
variable amounts of fatty atheromatous debris (Fig. 2B). Of
plaques from primary stenoses, 79% were so-called complex
plaques because of the presence of thrombus (61% of le-
sions) (Fig. 2C), calcification (47%), intraplaque hemorrhage
(41%) or surface ulceration (32%). Abundant surface throm-
bus, defined as >20% of the tissue consisting of thrombus as
estimated microscopically, was present at 46 sites (31%).
Calcium aggregates were of variable size, often involved
Table 1. Pathology of 218 Lesions Excised by Peripheral
Atherectomy in 100 Patients
Restenoses
Primary After After After PTA
Pathology Stenoses PTA ATH and ATH
Atherosclerotic plaque 150 1 10 1
FIT 15 0 0 0
Thrombus 5 0 0 0
Intimal hyperplasia 0 14 19 3
Total 170 15 29 4
ATH '= atherectomy; FIT '= fibrous intimal thickening; PTA = percuta-
neous transluminal balloon angioplasty.
both the plaque and the overlying surface thrombus and
occasionally appeared to have been cut across or through by
the device. Internal elastic lamina or arterial media, or both,
were observed in 90 (9%) of 964 atherosclerotic samples
from primary stenoses. Small portions of external elastic
lamina and adventitia were noted in one specimen from each
of two lesions.
Fibrous intimal thickening. Tissue consisting of mild
fibrous intimal thickening overlying internal elastic lamina
and media was excised from 15 primary stenoses (9%) (Fig.
3A). Irregular calcified nodules were seen within the media
in many instances, indicative of Monckeberg's medial cal-
cific sclerosis (Fig. 3B). Because the degree of intimal
thickening was minimal, histologic study provided no clear-
cut explanation for angiographic narrowing at these sites.
Stenoses may have been due to highly eccentric plaques or
the target lesions may not have been resected.
Organizing thrombus. Organizing thrombus alone, with-
out atherosclerotic plaque or arterial wall tissue, was excised
from five primary lesions (3%) from five patients (Fig. 3C).
Atherosclerosis was the likely predisposing factor for throm-
bosis in four of the five patients because typical atheroscle-
rotic plaque had been resected from other sites within the
same artery.
Postinterventional restenoses. Twenty-seven patients had
48 restenoses that had developed after balloon angioplasty
alone (l51esions in 8patients), atherectomy alone (29 lesions
in 16 patients), or both procedures (4 lesions in 3 patients)
(Fig. 1). The latter three patients had four postangioplasty
restenoses excised by atherectomy, followed by recurrent
restenoses treated by a second atherectomy procedure.
Histologically, restenoses were divided into two groups: I)
atherosclerotic plaque alone, and 2) intimal hyperplasia with
or without associated atherosclerotic plaque (Table I).
Atherosclerotic plaque. Overall, 25% of all restenoses
consisted of atherosclerotic plaque alone with features iden-
tical to those of plaque recovered from primary stenoses. No
evidence of plaque fracture or vessel wall repair was ob-
served in these samples. Eight percent of atherosclerotic
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Figure 3. A, Slightly thickened intima overlying a reduplicated
internal elastic lamina (arrow) and arterial media (elastic van Gieson
stain). B, Fibrous intimal thickening with focal calcification of the
media; internal elastic lamina is shown by the arrow (hematoxylin-
eosin stain). C, Strip of thrombus showing no evidence of organiza-
tion; no arterial wall is present (Masson's trichrome stain).
restenoses had thrombus that accounted for >20% of the
tissue excised. Fifteen percent of tissue samples in this
group contained some arterial media; none contained adven-
titia.
Intimal hyperplasia. Intimal hyperplasia was character-
ized by proliferation of smooth muscle cells within a loose
connective tissue matrix of sparse collagen fibrils and acid
mucopolysaccharides (Fig. 4A). Often, this cellular new
tissue appeared as a discrete layer overlying residual athero-
sclerotic plaque (Fig. 4B). The smooth muscle cells of this
neointimal growth differed from those of arterial media by
virtue of their larger size, stellate shape and haphazard
arrangement (Fig. 4C). Capillary ingrowth was a constant
finding, especially at the junction of residual plaque and new
tissue proliferation (Fig. 4D). Scattered lymphocytes and
hemosiderin-laden macrophages were occasionally found,
Figure 4. A, Intimal hyperplasia in postatherectomy restenosis
(Masson's trichrome stain). B, A discrete border (arrow) lies be-
tween neointimal growth (upper panel) and residual fibrous plaque
(lower panel) in this postangioplasty restenosis (Masson's trichrome
stain). C, Enlarged randomly oriented smooth muscle cells with
cytoplasmic projections (Masson's trichrome stain). D, New capil-
lary formation (arrow) within intimal hyperplasia of restenosis
(Masson's trichrome stain).
but calcium and lipid deposits were notably absent. A
significant amount of thrombus (>20% of estimated tissue
area) was observed at 25% of hyperplastic restenoses. Or-
ganizing thrombus coated the surface of neointima and was
interposed between old plaque and new tissue growth or was
lACC Vol. 15. No.2
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Table 2. Clinical Variables in 30 Patients With Arterial Restenoses Treated by Atherectomy
Initial No. Mean Time to HTN DM HCH SMK ASA DIP COUM
Procedure Pts. Age (yr) MIF Restenosis (mo) (%) (%) (%) (%) (%) (%) (%)
Angioplasty II 62 9/2 2 to 60 64 55 45 53 55 45 9
(mean 21.6)
Atherectomy 19 62 13/6 2 to II 58 21 42 47 89 56 6
(mean 6.5)
ASA = aspirin therapy; COUM = coumarin; DIP = dipyridamole; DM = diabetes mellitus; HCH = hypercholesterolemia; HTN = hypertension; MlF = male
to female ratio; Pts. = patients; SMK = cigarette smoking.
embedded within areas of intimal repair. Some arterial media
was present in 11% of tissue specimens in this group; none
contained adventitia. Intimal hyperplasia was observed as
early as 2 and as late as 60 months after initial vascular
intervention. Extensive neointimal proliferation was found
only at sites previously treated by angioplasty or atherec-
tomy.
Postangioplasty versus postatherectomy restenosis. Inti-
mal hyperplasia accounted for a higher percent of postan-
gioplasty restenoses (93%) than postatherectomy restenoses
(67%; p = 0.05) (Table 1). The cellularity, vascularity,
degree of fibrosis and content of inflammatory cells of
intimal hyperplasia did not differ in the two treatment
groups. Some thrombus was present in 67% of angioplasty
restenoses and 64% of atherectomy restenoses (p = 0.9),
with abundant thrombus present in 33% of angioplasty and
12% of atherectomy restenoses (p = 0.08). Although grooves
and crevices were sometimes noted within plaque underlying
intimal hyperplasia, the morphology of these disruptions was
not sufficiently distinct to permit differentiation of angio-
plasty from atherectomy renarrowings. The four restenoses
that occurred after both procedures could not be distin-
guished histologically from those that occurred after either
procedure alone.
Pathology of restenosis as related to clinical variables.
Several clinical variables were studied in relation to the
pathologic features of tissue excised at sites of restenosis
(Table 2). The clinical data for the three patients who
developed restenosis after both angioplasty and atherectomy
were included in both treatment groups. There were no
significant clinical differences between these two treatment
groups, with the exception that the mean time to restenosis
was 21.6 months for the angioplasty group as compared with
only 6.5 months for the atherectomy group (p = 0.008).
However, this difference is more apparent than real because
patients undergoing atherectomy were instructed to return
for follow-up study immediately if symptoms recurred,
whereas the patients undergoing angioplasty had been re-
ferred for treatment by many different outside physicians
and for a variety of clinical indications.
When all restenoses were considered together, irrespec-
tive ofthe original treatment, it was found that 12 restenoses
(25%) consisted of atherosclerotic plaque alone and 36 (75%)
showed intimal hyperplasia. None of the clinical variables
tested correlated with restenosis pathology (p > 0.05 for all).
The mean time to treatment was 9.9 months for restenosis
for intimal hyperplasia lesions and 10.3 months for athero-
sclerotic plaque restenoses (p = 0.9). Time to restenosis and
use of antiplatelet or anticoagulant therapy had no bearing
on the presence of small or substantial quantities of throm-
bus (p > 0.05 for all).
These clinical features were also analyzed for the angio-
plasty and atherectomy groups considered separately. For
the angioplasty restenosis group, intimal hyperplasia was
seen at a mean of 16.1 months after the initial procedure,
whereas the only atherosclerotic restenosis in this group was
removed at 42 months (p = 0.22). Other clinical factors also
showed no correlation with postangioplasty restenosis pa-
thology, and the presence or absence of thrombus was not
related to time to restenosis or medical therapy (p > 0.05 for
all). For the postatherectomy restenosis group, the mean
time to retreatment was 6 months for hyperplastic sites and
7.5 months for atherosclerotic lesions (p = 0.2). None of the
clinical variables correlated with restenosis morphology for
this group (p > 0.05 for all). Use of antiplatelet or anticoag-
ulant therapy showed no correlation with thrombus devel-
opment for the postatherectomy group (p > 0.05 for all).
However, the mean time to restenosis for those sites with
abundant thrombus was 9.1 months as compared with only
5.9 months for sites without extensive thrombus formation
(p = 0.05).
Discussion
Mechanism of atherectomy. Before clinical trials, we per-
formed transluminal atherectomy on 70 segments of athero-
sclerotic human cadaver arteries using early atherectomy
catheter prototypes (2). These experiments showed that
pieces of plaque could be excised and retrieved by the device
in a reproducible manner. Serial cross sections of treated
arteries revealed concave, rounded and smooth defects cut
into atherosclerotic plaques. Furthermore, the plaque frac-
tures and dissections typical of angioplasty were not present
(3-10). It was postulated that atherectomy might have a
lower acute complication rate and provide more predictable
clinical results than those that occur with balloon angio-
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plasty. Our early experience (1) with directed atherectomy
for symptomatic peripheral vascular disease demonstrated
an angiographic success rate of 87%, with only 2.2% of
treated lesions showing any angiographic evidence of dissec-
tion. No vessel wall perforation has occurred.
Pathology of excised primary stenoses. We found that 88%
of excised primary, previously untreated stenoses consisted
of atherosclerotic plaque. Almost two-thirds of these lesions
were associated with surface thrombus, calcification, intra-
plaque hemorrhage or plaque erosions, or a combination of
these lesions. Surface thrombus was the most common of
these findings, and it likely contributed to the severity of
narrowing present at one-third of primary stenoses. Indeed,
thrombus only was recovered from five sites, including two
with total occlusion. Acute nonocclusive thrombosis devel-
oped immediately after atherectomy in one patient in this
series and was successfully lysed by intravascular streptoki-
nase. Study of the tissues excised by atherectomy from this
site revealed a large quantity of organizing thrombus and
atherosclerotic plaque, suggesting that preexisting thrombus
may be a risk factor for postatherectomy thrombosis. Angio-
graphic evidence of thrombus before angioplasty has been
found to be associated with a higher rate of abrupt reclosure
and thrombosis (11).
Although 9% of samples excised by atherectomy from
primary stenoses contained some arterial media and two
samples also had small areas of adventitia, no patient had
either angiographic or clinical evidence of vessel wall perfo-
ration. It is not known if incision of the arterial media during
atherectomy will influence subsequent healing of the vessel
wall and the restenosis rate.
Pathology ofExcised Restenoses
Intimal hyperplasia. Forty-eight lesions studied were re-
stenoses that developed after prior angioplasty (15 lesions),
atherectomy (29 lesions) or both procedures (4 lesions).
Three-quarters of these restenoses were proved microscop-
ically to be due to intimal hyperplasia, often superimposed
on residual atherosclerotic plaque. These findings are con-
sistent with the morphology of postangioplasty coronary
artery restenosis as observed at autopsy (11-15). There were
no appreciable differences in the hyperplastic lesions that
occurred after angioplasty or atherectomy, evidence that the
healing response of the vessel is nonspecific and independent
of the mechanism by which the artery was initially disrupted.
Intimal proliferation that closely resembles postinterven-
tional restenosis may also be seen after carotid endarterec-
tomy and in synthetic vascular grafts (16,17).
The pathogenesis of intimal hyperplasia after vascular
intervention remains largely unknown. Release of mitogens
such as platelet-derived growth factor from adherent plate-
lets at sites of arterial injury is one proposed cause of smooth
muscle cell proliferation and migration into the intima
(18,19). However, clinical angioplasty trials (20,21) have
yielded conflicting data concerning the utility of antiplatelet
agents in preventing restenosis. Our results clearly show that
aspirin and dipyridamole do not prevent intimal hyperplasia.
Whether or not these agents retard or alter the course of
progression of this arterial lesion remains to be seen. Anti-
platelet agents were also found not to inhibit thrombus
formation at sites of restenosis. Tissues recovered from 33%
of angioplasty and 12% of atherectomy restenoses (p = 0.08)
showed abundant thrombus that may have contributed to the
severity of luminal narrowing.
Atherosclerotic plaque. Occasional arteries examined at
autopsy after balloon angioplasty have shown only plaque,
without cracks, dissections, intimal hyperplasia or any other
change that could be attributed to the procedure (10,22).
Twenty-five percent of restenoses resected by atherectomy
in this study consisted entirely of atherosclerotic plaque,
without concurrent features of intimal hyperplasia. For some
angioplasty cases, it is possible that the lesion was only
stretched initially and that elastic recoil of the vessel even-
tually caused renarrowing without a proliferative cellular
response. Also, atherectomy may have removed only ath-
erosclerotic lesions immediately adjacent to previous inter-
vention sites, this being especially likely for diffuse stenoses.
Finally, the natural morphologic history of restenosis is
unknown, and it may be that intimal hyperplasia becomes
progressively more fibrotic and less cellular with time.
Atherectomy of such completely "healed" segments would
yield tissue indistinguishable from that of ordinary athero-
sclerotic plaque. However, in the current study, there was
no correlation between time to retreatment and the pathol-
ogy of restenoses. Intimal hyperplasia was observed as late
as 60 months after angioplasty in two patients. Unexplained,
and perhaps coincidental, was the presence of atheroscle-
rotic plaque alone at a higher percent of atherectomy (33%)
than angioplasty (7%) restenoses (p = 0.05). None of the
other clinical variables examined correlated with the pathol-
ogy of restenotic sites.
Limitations. This study does not provide a complete
pathologic description of primary stenoses and restenoses
because strips of arterial wall, not complete cross sections of
arteries, were evaluated. This limited our ability to analyze
certain features such as eccentricity of disease, severity of
medial damage, precise quantity of thrombus and distribu-
tion of neointimal hyperplasia about the lumen. Also, a
larger number of cases needs to be studied to clarify the
long-term morphology and progression of restenosis.
Conclusions. Directed atherectomy is an effective treat-
ment for symptomatic peripheral arterial disease. Atherec-
tomy can be performed in conjunction with other treatment
modalities, such as balloon angioplasty, thus providing the
ability to tailor therapy to an individual patient's circum-
stances. Histologic examination of tissues removed by
atherectomy can yield important information regarding the
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arterial pathology present, the efficacy of the procedure and
the process of postintervention arterial healing and resteno-
sis. We recommend that all tissue recovered by atherectomy
be submitted for gross and microscopic analysis. More
advanced studies, including electron microscopy, immuno-
histochemistry and tissue culture, also may further our
understanding of vessel wall repair and restenosis .after
vascular intervention.
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